Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanistic Involvement of Long Non-Coding RNAs in Oncotherapeutics Resistance in Triple-Negative Breast Cancer
Samarth Kansara, Vijay Pandey, Peter E. Lobie, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1511-1511
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Mahshid Deldar Abad Paskeh, Maliheh Entezari, Sepideh Mirzaei, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 362
Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
Sepideh Mirzaei, Ali Zarrabi, Farid Hashemi, et al.
Cancer Letters (2021) Vol. 509, pp. 63-80
Closed Access | Times Cited: 193
Long non-coding RNAs in the doxorubicin resistance of cancer cells
Saeed Ashrafizaveh, Milad Ashrafizadeh, Ali Zarrabi, et al.
Cancer Letters (2021) Vol. 508, pp. 104-114
Open Access | Times Cited: 152
LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack
Jaganathan Venkatesh, Marie‐Claire D. Wasson, Justin M. Brown, et al.
Cancer Letters (2021) Vol. 509, pp. 81-88
Open Access | Times Cited: 136
Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Elena Okina, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 124
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response
Milad Ashrafizadeh, Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 110
Non-coding RNA-based regulation of inflammation
Milad Ashrafizadeh, Ali Zarrabi, Ebrahim Mostafavi, et al.
Seminars in Immunology (2022) Vol. 59, pp. 101606-101606
Closed Access | Times Cited: 70
Noncoding RNAs as regulators of STAT3 pathway in gastrointestinal cancers: Roles in cancer progression and therapeutic response
Milad Ashrafizadeh, Chakrabhavi Dhananjaya Mohan, Shobith Rangappa, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1263-1321
Closed Access | Times Cited: 59
The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential
Gouri Pandya, Anuradha Kirtonia, Gautam Sethi, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1874, Iss. 2, pp. 188423-188423
Closed Access | Times Cited: 128
The pleiotropic role of transcription factor STAT3 in oncogenesis and its targeting through natural products for cancer prevention and therapy
Manoj Garg, Muthu K. Shanmugam, Vipul Bhardwaj, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 3, pp. 1291-1336
Closed Access | Times Cited: 113
Ferroptosis: An emerging approach for targeting cancer stem cells and drug resistance
Sara M. Elgendy, Shatha K. Alyammahi, Dima W. Alhamad, et al.
Critical Reviews in Oncology/Hematology (2020) Vol. 155, pp. 103095-103095
Closed Access | Times Cited: 103
Progress in Delivery of siRNA-Based Therapeutics Employing Nano-Vehicles for Treatment of Prostate Cancer
Milad Ashrafizadeh, Kiavash Hushmandi, Ebrahim Rahmani Moghadam, et al.
Bioengineering (2020) Vol. 7, Iss. 3, pp. 91-91
Open Access | Times Cited: 85
Long noncoding RNAs (lncRNAs) in pancreatic cancer progression
Milad Ashrafizadeh, Navid Rabiee, Alan Prem Kumar, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 8, pp. 2181-2198
Closed Access | Times Cited: 55
Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients
Sunny Kumar, Mouli Chatterjee, Pratyasha Ghosh, et al.
Genes & Diseases (2022) Vol. 10, Iss. 4, pp. 1318-1350
Open Access | Times Cited: 50
Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Yalda Saghari, et al.
International Journal of Biological Macromolecules (2022) Vol. 206, pp. 435-452
Closed Access | Times Cited: 44
Non-coding RNAs and macrophage interaction in tumor progression
Maliheh Entezari, Mehrdokht Sadrkhanloo, Mohsen Rashidi, et al.
Critical Reviews in Oncology/Hematology (2022) Vol. 173, pp. 103680-103680
Closed Access | Times Cited: 39
MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, et al.
European Journal of Pharmacology (2020) Vol. 892, pp. 173660-173660
Closed Access | Times Cited: 68
PTEN, a Barrier for Proliferation and Metastasis of Gastric Cancer Cells: From Molecular Pathways to Targeting and Regulation
Milad Ashrafizadeh, Masoud Najafi, Hui Li Ang, et al.
Biomedicines (2020) Vol. 8, Iss. 8, pp. 264-264
Open Access | Times Cited: 61
Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospects
Milad Ashrafizadeh, Sepideh Mirzaei, Kiavash Hushmandi, et al.
Life Sciences (2021) Vol. 278, pp. 119649-119649
Closed Access | Times Cited: 55
LncRNA as a multifunctional regulator in cancer multi-drug resistance
Jiaying He, Shaomi Zhu, Xin Liang, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 8, pp. 1-15
Closed Access | Times Cited: 52
Long noncoding RNAs in triple‐negative breast cancer: A new frontier in the regulation of tumorigenesis
Krishan Kumar Thakur, Aviral Kumar, Kishore Banik, et al.
Journal of Cellular Physiology (2021) Vol. 236, Iss. 12, pp. 7938-7965
Closed Access | Times Cited: 50
UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology
Milon Mondal, Daniel Conole, Jaya Nautiyal, et al.
British Journal of Cancer (2021) Vol. 126, Iss. 1, pp. 24-33
Open Access | Times Cited: 49
Interplay between SOX9 transcription factor and microRNAs in cancer
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, et al.
International Journal of Biological Macromolecules (2021) Vol. 183, pp. 681-694
Closed Access | Times Cited: 47
Gene regulation by antisense transcription: A focus on neurological and cancer diseases
Sajad Najafi, Shing Cheng Tan, Pourya Raee, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 145, pp. 112265-112265
Open Access | Times Cited: 44
Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Farid Hashemi, et al.
Life Sciences (2021) Vol. 288, pp. 119948-119948
Closed Access | Times Cited: 42
Page 1 - Next Page

Scroll to top